In Form 10-K filed on October 24, 2016, Unilife Corporation’s auditor, KPMG LLP, raised substantial doubt about the Company’s ability to continue as a going concern. According to KPMG, the Company has incurred recurring losses from operations and has limited cash resources. The Company expects to generate cash receipts from wearable injector customers during fiscal 2017 and the Company continues to have business development discussions with current and prospective wearable injector customers. The Company is, however, unable to predict the amount, if any, or the timing of such receipts or any proceeds from these business development discussions. The Company has engaged a financial advisory firm to assist with fundraising efforts. There is no assurance that the financial advisory firm will be successful in these efforts. Read more on distressed companies.